Analyze forecasts and alternative better and worse scenarios from 2017 to 2040 for 250 causes of death, life expectancy, years of life lost (YLLs) as well as risk-attributable deaths and YLLs. Use treemaps, arrow diagrams, decomposition plots, line charts, maps and others to compare across countries and with regions of the world.
In celebration of the 20th anniversary of the Global Burden of Disease study, those who have invested and been impacted by this work reflect on the past two decades.
Global stroke epidemiology is changing rapidly. Although age-standardized rates of stroke mortality have decreased worldwide in the past two decades, the absolute numbers of people who have a stroke every year, and live with the consequences of stroke or die from their stroke, are increasing. Regular updates on the current level of stroke burden are important for advancing our knowledge on stroke epidemiology and facilitating organization and planning of evidence-based stroke care.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. Learn more about the new findings.
The two lead researchers behind the original Global Burden of Disease study – now IHME faculty members – will discuss some of the preliminary preliminary estimates from the much anticipated GBD 2010 Study at the University of Queensland's Global Leadership Series in Washington, DC.
The public is invited to attend a forum on the Global Burden of Disease at World Health Organization Headquarters in Geneva on December 18. This forum will be an opportunity to bring the GBD network of researchers together with WHO staff and Member State representatives to discuss the latest...
Diabetes is an increasingly important health threat in many African countries, and is fast becoming a leading cause of non-communicable-disease-related death and disability on the continent. A new report by IHME, launched in Nairobi at the Pan African World Diabetes Day Forum, is helping the Kenyan Ministry of Health frame its strategy for tackling the disease.
On the days of the review meeting, December 7 and 8, please visit this page to view the live webcast and post your comments and questions. To submit a question, select the chat icon in the upper right hand corner of the Livestream window. Our presenter will answer the question at an appropriate t...
In Norway, the government is helping improve the science behind the Global Burden of Disease (GBD) study and incorporating it into their decision-making. The March 2016 launch of the report on GBD findings in Norway has received extensive coverage by the Norwegian media.
The Global Burden of Disease (GBD) study assesses health losses from diseases, injuries, and risk factors using disability-adjusted life-years, which need a set of disability weights to quantify health levels associated with nonfatal outcomes. The objective of this study was to estimate disability weights for the GBD 2013 study.
Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent with the estimates of the numbers of deaths in the GBD. The present iteration of the GBD, GBD 2017, improves on previous assessments and provides timely estimates of the mortality experience of populations globally.
Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns deviate from these trends.
Over the past few years, the Global Burden of Disease (GBD) study has grown a network of expert collaborators with an array of experience, competencies, and disciplines, and it is this diversity of perspective that makes GBD the most comprehensive view of global health burden in the world. One collaborator, Dr. Jayaraman, discussed her unique vantage point as a clinician in October during the GBD 2015 launch event, and we had the opportunity to learn more about Dr. Jayaraman’s experiences after the event.
Trends in the world’s most populous countries have a huge impact on the global health picture overall. If the child mortality rate improves even modestly in a country as big as India, it can have enormous implications for the total number of children who die before the age of 5 every year. That’s one of the reasons it was such an important step for global health efforts when China took an active role in the Global Burden of Disease project.
“Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017” is based on more data than ever before and includes 68,781 data sources used for the analysis of nonfatal causes of disease and injury. GBD 2017 added 19 new causes to its nonfatal analysis, for a total of 354 causes. The study includes a more detailed analysis of disability than previous versions of GBD.
The Global Burden of Disease (GBD) enerprise has consistently grown its collaborator base. At the time of the GBD 2015 launch in October 2016, there were 1,870 collaborators from 124 countries and 3 territories.
The articles of this issue of the Brazilian Journal of Epidemiology are the result of efforts to estimate and analyze the burden of disease in Brazil and in its states.
This update to the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) includes an important new feature: for the first time, population and fertility estimates were produced by the GBD collaborators. Those estimates confirm and extend our understanding of key population trends, including those related to health.
Each year, the Global Burden of Disease (GBD) study hosts a series of annual review meetings in order to foster scientific dialogue regarding key aspects of the study methods. The agenda varies each year with some critical topics being reviewed annually and others rotating year-to-year to ensure ...